COMMUNIQUÉS West-GlobeNewswire

Autonomix Medical, Inc. Reports Positive Subgroup Results Demonstrating Sustained Improvements in Quality of Life from Post Hoc Analysis of Pancreatic Cancer PoC Study
17/11/2025
EORTC QLQ-C30 subgroup results confirm broad and durable quality-of-life improvements across disease stages and metastasis status, complementing previously reported pain reduction and opioid-free outcomes Late-stage [...]
ProPhase Labs Urges Shareholders to Vote by November 23 on Proxy Proposals
17/11/2025
UNIONDALE, NY, Nov. 17, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) reminds shareholders of record as of October 20, 2025, of the Company's upcoming Special Meeting of Stockholders, which will be held on [...]
Protara Therapeutics to Present New Interim Data from Phase 2 ADVANCED-2 Trial of TARA-002 in BCG-Naïve NMIBC Patients at the 26th Annual Meeting of the Society of Urologic Oncology
17/11/2025
NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced that [...]
Radiopharm Theranostics Announces 50% Enrollment in Phase 2b Clinical Trial of RAD101 Imaging in Brain Metastases
17/11/2025
Early patient data from Phase 2b clinical trial showed significant and selective tumor uptake in brain metastases compared to MRI Phase 2b clinical trial expected to complete enrollment and have topline data in 1H26 [...]
Cerevance to Participate in the TD Cowen Treatment Advancements in Obesity and Related Disorders Summit
17/11/2025
BOSTON, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Cerevance, a clinical-stage biopharmaceutical company advancing multiple cell type-specific therapies for the treatment of neurodegenerative diseases and obesity, today [...]
Grace Therapeutics to Participate in 16th Annual Craig-Hallum Alpha Select Conference
17/11/2025
PRINCETON, N.J., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Grace Therapeutics, Inc. (Nasdaq: GRCE) (Grace Therapeutics or the Company), a late-stage, biopharma company advancing GTx-104, a clinical-stage, novel, injectable [...]
Communiqué de presse : Sanofi réaffirme son engagement à innover depuis la France pour le monde
17/11/2025
Choose France – Édition France 2025 Sanofi réaffirme son engagement à innover depuis la France pour le monde Paris, 17 novembre 2025. À l'occasion du premier sommet Choose France dédié aux entreprises françaises, Sanofi [...]
Zelluna ASA: New share capital registered
17/11/2025
Oslo, Norway, 17 November, 2025: Reference is made to the stock exchange announcement made by Zelluna ASA (the "Company") on 3 November 2025 regarding the successful private placement of 5,500,000 new shares (the " [...]
Ramsay Sante : conditions of availability and consultation of the preparatory documents for the Ramsay Générale de Santé General Meeting of December 11, 2025
17/11/2025
PRESS RELEASE Paris, 14 th November 2025 COMBINED GENERAL MEETING OF DECEMBER 11, 2025 Conditions of availability and consultation of the preparatory documents for the Ramsay Générale de Santé General Meeting of [...]
RAMSAY SANTE : modalités de mise à disposition ou de consultation des documents préparatoires à l'Assemblée générale de Ramsay Générale de Santé du 11 décembre 2025
17/11/2025
COMMUNIQUÉ DE PRESSE Paris, le 14 novembre 2025 ASSEMBLEE GENERALE MIXTE DU 11 DECEMBRE 2025 Modalités de mise à disposition ou de consultation des documents préparatoires à l’Assemblée générale de Ramsay Générale de [...]
Clue Expands Wearable Integrations with Withings, Ultrahuman, WHOOP, Huawei, Polar, Fitbit, Noise and Luna, Unlocking Deeper Insights into Women’s Health
17/11/2025
LONDON, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Clue , the #1 women-led period and cycle tracker trusted by over 100 million worldwide, has today announced expanded integrations with leading wearable partners Withings , [...]
Nxera Pharma Shares Video Interviews with Major Shareholders on Its Official YouTube Channel
17/11/2025
Perspectives from Nxera’s major shareholders provide deeper insights into their investment views and confidence in the Company’s strategy Tokyo, Japan and Cambridge and London, UK, 17 November 2025 – Nxera Pharma Co., [...]
Inventiva announces full exercise of Underwriters’ Option, bringing proceeds of Offering to approximately $172.5M
17/11/2025
Daix (France), New York City (New York, United States), November 17, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) (" Inventiva " or the " Company "), a clinical-stage biopharmaceutical company focused on the [...]
Inventiva annonce l’exercice intégral de l’Option des Banques portant le montant de l'Offre à environ 172,5 millions de dollars
17/11/2025
Daix (France), New York City (New York, États-Unis), le 17 novembre 2025 – Inventiva (Euronext Paris et Nasdaq : IVA) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le développement de [...]
Nxera Announces Focused Restructuring to Enhance Path to Profitability
17/11/2025
Tokyo, Japan and Cambridge and London, UK, 17 November 2025 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) today announced a focused restructuring designed to concentrate investment and resources on [...]
TME Pharma announces receipt of agreements in principle to extend certain bond agreements
17/11/2025
TME Pharma announces receipt of agreements in principle to extend certain bond agreements Berlin, Germany , November 17, 2025, 08.00am CET – TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology [...]
TME Pharma announces receipt of agreements in principle to extend certain bond agreements
17/11/2025
TME PHARMA ANNONCE AVOIR REÇU DES ACCORDS DE PRINCIPE POUR PROLONGER CERTAINS ACCORDS D'OBLIGATIONS Berlin, Allemagne, le 17 novembre 2025, 8h00 CET – TME Pharma N.V. (Euronext Growth Paris : ALTME), une société de [...]
James M. O’Brien Appointed Chief Financial Officer at Mesoblast
17/11/2025
NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that in connection with the Company’s [...]
Ascend Vitality Expands National Telehealth Network to Provide Physician-Directed Access to Compounded Peptide Therapies
17/11/2025
Sheridan, WY, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Ascend Vitality announced today that it has expanded its fully licensed telehealth operations across all 50 states, reinforcing its position as a provider of physician- [...]

Pages